Lv11
50 积分 2024-02-06 加入
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
3个月前
已完结
Modulation of human GABAA and glycine receptor currents by menthol and related monoterpenoids
5个月前
已完结
Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions
5个月前
已关闭
The anti-inflammatory and immunological properties of SGLT-2 inhibitors
5个月前
已完结
Cardiovascular benefit of SGLT2 inhibitors
6个月前
已完结
Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus
6个月前
已完结
Characterization of a robust mouse model of heart failure with preserved ejection fraction
6个月前
已完结
A united vision for cardiovascular–kidney–metabolic health
6个月前
已完结
Gene amplification as a form of population-level gene expression regulation
7个月前
已完结
Diabetes and cardiovascular disease. The Framingham study
7个月前
已完结
皖公网安备34019202002308
